2972 Federal Register / Vol. 65, No. 12 / Wednesday, January 19, 2000 / Notices

Place: Natcher Building, Conference Room

D, 45 Center Drive, Bethesda, MD 20892.

Closed: 11 a.m. to 11:45 a.m.

Agenda: To review and evaluate the

Intrumural program.

Place: Natcher Building, Conference Room

D, 45 Center Drive, Bethesda, MD 20892.

Open: 12:45 p.m. to 2:45 p.m.

Agenda: Discussion of Peer Review Issues

and Program Highlights

Place: Natcher Building, Conference Room

D, 45 Center Drive, Bethesda, MD 20892.

Closed: 3 p.m. to Adjournment.

Agenda: To review and evaluate

applications.

Place: Natcher Building, Conference Room

D. 45 Center Drive, Bethesda, MD 20892

Contact Person: Miriam F. Kelty, PHD,

Director, Office of Extramural Affairs,

National Institute on Aging, National

Institutes of Health, 7201 Wisconsin Avenue,

Suite 2C218, Bethesda, MD 20892, 301–496–

9322.

(Catalogue of Federal Domestic Assistance

Program Nos. 93.866, Aging Research,

National Institutes of Health, (HHS)

Dated: January 11, 2000.

LaVerne Y. Stringfield,

Director, Office of Federal Advisory

Committee Policy.

[FR Doc. 00–1138 Filed 1–18–00; 8:45 am]

BILLING CODE 4140–01–M

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

National Institutes of Health

National Institute of Diabetes and

Digestive and Kidney Diseases; Notice

of Closed Meetings

Pursuant to section 10(d) of the

Federal Advisory Committee Act, as

amended (5 U.S.C. Appendix 2), notice

is hereby given of the following

meetings.

The meetings will be closed to the

public in accordance with the

provisions set forth in sections

552b(c)(4) and 522b(c)(6), Title 5 U.S.C.,

as amended. The grant applications and

the discussions could disclose

confidential trade secrets or commercial

property such as patentable material,

and personal information concerning

individuals associated with the grant

applications, the disclosure of which

would constitute a clearly unwarranted

invasion of personal privacy.

Name of Committee: National Institute of

Diabetes and Digestive and Kidney Diseases

Special Emphasis Panel, ZDK1–GRB–D (J1).

Date: January 20, 2000.

Time: 2:00 p.m. to 4:00 p.m.

Agenda: To review and evaluate grant

applications.

Place: Natcher Building, 45 Center Drive,

Room 6AS37F, Bethesda, MD 20892.

(Telephone Conference Call).

Contact Person: Ann A. Hagan, PHD, Chief,

Review Branch, National Institute of

Diabetes, Digestive and Kidney Diseases,

National Institutes of Health, PHS, DHHS,

Rm. 6AS37, Bldg. 45, Bethesda, MD 20892,

(301) 594–8886.

This notice is being published less than 15

days prior to the meeting due to the timing

limitations imposed by the review and

funding cycle.

Name of Committee: National Institute of

Diabetes and Digestive and Kidney Diseases

Special Emphasis Panel, ZDK1–GRB–C (J4).

Date: January 25, 2000.

Time: 1:00 p.m. to 2:00 p.m.

Agenda: To review and evaluate grant

applications.

Place: National Institutes of Health,

Natcher Bldg., 45 Center Drive, Room 6AS–

37, Bethesda, MD 20892. (Telephone

Conference Call).

Contact Person: Dan E. Matsumoto, PHD,

Scientific Review Administrator, Review

Branch, DEA, NIDDK, Natcher Building,

Room 6AS37B, National Institutes of Health,

Bethesda, MD 20892–6600, (301) 594–8894.

This notice is being published less than 15

days prior to the meeting due to the timing

limitations imposed by the review and

funding cycle.

(Catalogue of Federal Domestic Assistance

Program Nos. 93.847, Diabetes,

Endocrinology and Metabolic Research;

93.848, Digestive Diseases and Nutrition

Research; 93.849, Kidney Diseases, Urology

and Hematology Research, National Institutes

of Health, HHS)

Dated: January 11, 2000.

LaVerne Y. Stringfield,

Director, Office of Federal Advisory

Committee Policy.

[FR Doc. 00–1139 Filed 1–18–00; 8:45 am]

BILLING CODE 4140–01–M

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

National Institutes of Health

National Institute on Drug Abuse;

Notice of Meeting

Pursuant to section 10(d) of the

Federal Advisory Committee Act, as

amended ((5 U.S.C. Appendix 2), notice

is hereby given of a meeting of the

National Advisory Council on Drug

Abuse.

The meeting will be open to the

public as indicated below, with

attendance limited to space available.

Individuals who plan to attend and

need special assistance, such as sign

language interpretation or other

reasonable accommodations, should

notify the Contact Person listed below

in advance of the meeting.

The meeting will be closed to the

public in accordance with the

provisions set forth in sections

552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,

as amended. The grant applications and

the discussions could disclose

confidential trade secrets or commercial

property such as patentable material,

and personal information concerning

individuals associated with the grant

applications, the disclosure of which

would constitute a clearly unwarranted

invasion of personal privacy.

Name of Committee: National Advisory

Council on Drug Abuse.

Date: February 8–9, 2000.

Closed: February 8, 200, 1:00 p.m. to

Adjournment.

Agenda: To review and evaluate grant

applications.

Place: Neuroscience Center, National

Institutes of Health, 6001 Executive Blvd.,

Bethesda, MD 20892.

Open: February 9, 2000, 9:00 a.m. to

Adjournment.

Agenda: This portion of the meeting will

be open tobe public for announcements and

reports of administrative, legislative and

program developments in the drug abuse

field.

Place: Neuroscience Center, National

Institutes of Health, 6001 Executive Blvd.,

Bethesda, MD 20892.

Contact Person: Teresa Levitin, PhD,

Director, Office of Extramural Affairs,

National Institute on Drug Abuse, National

Institutes of Health, DHHS, Bethesda, MD

20892–9547, (301) 443–2755.

(Catalogue of Federal Domestic Assistance

Program Nos. 93.277, Drug Abuse Scientist

Development Award for Clinicians, Scientist

Development Awards, and Research Scientist

Awards; 93.278, Drug Abuse National

Research Service Awards for Research

Training; 93.279, Drug Abuse Research

Programs, National Institutes of Health, HHS

Dated: January 11, 2000.

LaVerne Y. Stringfield,

Director, Office of Federal Advisory

Committee Policy.

[FR Doc. 00–1140 Filed 1–18–00; 8:45 am]

BILLING CODE 4140–01–M

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

National Institutes of Health

National Institutes of Diabetes and

Digestive and Kidney Diseases; Notice

of Meetings

Pursuant to section 10(d) of the

Federal Advisory Committee Act, as

amended (5 U.S.C. Appendix 2), notice

is hereby given of meetings of the

National Diabetes and Digestive and

Kidney Diseases Advisory Council.

The meetings will be open to the

public as indicated below, with

attendance limited to space available.

Individuals who plan to attend and

need special assistance, such as sign

language interpretation or other

reasonable accommodations, should

notify the Contact Person listed below

in advance of the meeting.